Lantern Pharma Ownership | Who Owns Lantern Pharma?
Lantern Pharma Ownership Summary
Lantern Pharma is owned by 18.99% institutional investors, 17.15% insiders, and 63.86% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 7.93% of LTRN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.37% of its assets in Lantern Pharma shares.
LTRN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lantern Pharma | 18.99% | 17.15% | 63.86% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bios capital management, lp | 864.43K | 7.93% | $1.18M |
| Vanguard group | 384.04K | 3.54% | $1.16M |
| Cm management | 250.00K | 2.29% | $342.50K |
| Renaissance | 116.00K | 1.06% | $158.92K |
| Geode capital management | 111.65K | 1.02% | $152.98K |
| Westside investment management | 50.05K | 0.46% | $68.57K |
| Voss capital | 50.00K | 0.46% | $68.50K |
| Vanguard fiduciary trust | 49.61K | 0.46% | $67.96K |
| Newedge advisors | 47.28K | 0.44% | $205.67K |
| Blackrock funding, inc. /de | 45.27K | 0.42% | $62.02K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bios capital management, lp | 864.43K | 2.24% | $1.18M |
| Cm management | 250.00K | 0.29% | $342.50K |
| Westside investment management | 50.05K | 0.01% | $68.57K |
| Voss capital | 50.00K | 0.00% | $68.50K |
| Newedge advisors | 47.28K | 0.00% | $205.67K |
| Curio wealth | 2.00K | 0.00% | $2.74K |
| Horizon kinetics asset management | 26.37K | 0.00% | $36.13K |
| Renaissance | 116.00K | 0.00% | $158.92K |
| Davenport | 23.81K | 0.00% | $32.63K |
| Cibc private wealth group | 15.43K | 0.00% | $46.76K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard fiduciary trust | 49.61K | - | 49.61K |
| Cm management | 250.00K | 0.29% | 25.00K |
| Blackrock | 39.84K | - | 20.18K |
| Two sigma investments, lp | 16.04K | 0.00% | 16.04K |
| Cibc private wealth group | 15.43K | 0.00% | 15.43K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bios capital management, lp | 864.43K | 2.24% | -145.07K |
| Perigon wealth management | - | - | -39.39K |
| Redmond asset management | - | - | -37.27K |
| Citadel advisors | - | - | -32.90K |
| Susquehanna group, llp | - | - | -28.82K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 49.61K | - | 49.61K | $67.96K |
| Two sigma investments, lp | 16.04K | 0.00% | 16.04K | $69.78K |
| Cibc private wealth group | 15.43K | 0.00% | 15.43K | $46.76K |
| Millennium management | 10.13K | - | 10.13K | $47.33K |
| Vanguard global advisers | 2.35K | - | 2.35K | $3.23K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -2.00 |
| Federated hermes | -74.00 |
| Stone house investment management | -200.00 |
| Cypress capital | -200.00 |
| Newbridge financial services group | -200.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 32 | -8.57% | 2,069,248 | -9.26% | 18 | 4.29% | 14 | 7.69% | 8 | -11.11% |
| Dec 31, 2025 | 7 | -78.13% | 681,528 | -70.17% | 6 | 1.40% | - | -100.00% | 3 | -62.50% |
| Sep 30, 2025 | 7 | -78.79% | 492,542 | -78.02% | 4 | 1.06% | 1 | -94.74% | 2 | -60.00% |
| Jun 30, 2025 | 33 | - | 2,240,755 | -7.55% | 20 | 4.11% | 17 | 30.77% | 6 | - |
| Mar 31, 2025 | 33 | -2.94% | 2,423,715 | -3.04% | 22 | 4.17% | 13 | -7.14% | 6 | -40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 256.11K | 2.37% | - |
| Vanguard Total Stock Mkt Idx Inv | 250.63K | 2.23% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 81.44K | 0.72% | - |
| Fidelity Extended Market Index | 60.43K | 0.53% | 14.55K |
| Horizon Kinetics Medical ETF | 26.37K | 0.23% | - |
| DFA US Targeted Value I | 21.64K | 0.20% | - |
| iShares Micro-Cap ETF | 21.51K | 0.19% | - |
| Extended Equity Market Fund B | 17.85K | 0.16% | - |
| Extended Equity Market Fund E | 17.85K | 0.16% | - |
| Blackrock Extended Mkt Fund CF | 17.85K | 0.16% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 12, 2026 | Schalop Lee Troy | - | Buy | $100.00K |
| May 12, 2026 | Schalop Lee Troy | - | Sell | $110.19K |
| May 12, 2026 | KEYSER D JEFFREY | - | Sell | $110.19K |
| May 12, 2026 | KEYSER D JEFFREY | - | Buy | $100.00K |
| Jun 13, 2025 | Fletcher Aaron G.L. | - | Sell | $13.45K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 4 | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 70 |
LTRN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools